Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable
- PMID: 38848082
- DOI: 10.1001/jama.2024.10333
Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable
Similar articles
-
Fair Allocation of GLP-1 and Dual GLP-1-GIP Receptor Agonists.N Engl J Med. 2024 May 30;390(20):1839-1842. doi: 10.1056/NEJMp2400978. Epub 2024 Apr 17. N Engl J Med. 2024. PMID: 38630999 No abstract available.
-
GLP-1 Medication Use for Type 2 Diabetes Has Soared.JAMA. 2024 Sep 24;332(12):952-953. doi: 10.1001/jama.2024.18219. JAMA. 2024. PMID: 39212980
-
Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program.JAMA Netw Open. 2020 Oct 1;3(10):e2020969. doi: 10.1001/jamanetworkopen.2020.20969. JAMA Netw Open. 2020. PMID: 33057641 Free PMC article.
-
New Injectable Agents for the Treatment of Type 2 Diabetes Part 2-Glucagon-Like Peptide-1 (GLP-1) Agonists.Am J Med. 2018 Nov;131(11):1304-1306. doi: 10.1016/j.amjmed.2018.05.043. Epub 2018 Jul 2. Am J Med. 2018. PMID: 29969616 Review.
-
Glucagon like peptide-1 and its receptor agonists: Their roles in management of Type 2 diabetes mellitus.Diabetes Metab Syndr. 2017 Jul-Sep;11(3):225-230. doi: 10.1016/j.dsx.2016.09.003. Epub 2016 Sep 15. Diabetes Metab Syndr. 2017. PMID: 27884496 Review.
Cited by
-
GLP-1 receptor agonist use in elective lumbar spine surgery: Reduced pseudarthrosis rates and favorable safety profile.J Orthop. 2025 May 8;65:227-232. doi: 10.1016/j.jor.2025.05.018. eCollection 2025 Jul. J Orthop. 2025. PMID: 40502373
-
Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report.Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):382-384. doi: 10.1080/21678421.2024.2446847. Epub 2025 Jan 7. Amyotroph Lateral Scler Frontotemporal Degener. 2025. PMID: 39772789 No abstract available.
-
Hormonal modulation, mitochondria and Alzheimer's prevention: the role of GLP-1 agonists and estrogens.Front Mol Biosci. 2025 Jun 26;12:1622186. doi: 10.3389/fmolb.2025.1622186. eCollection 2025. Front Mol Biosci. 2025. PMID: 40642529 Free PMC article. Review.
-
Semaglutide Eligibility Across All Current Indications for US Adults.JAMA Cardiol. 2025 Jan 1;10(1):96-98. doi: 10.1001/jamacardio.2024.4657. JAMA Cardiol. 2025. PMID: 39556764
-
GLP-1 and Its Analogs: Does Sex Matter?Endocrinology. 2025 Jan 6;166(2):bqae165. doi: 10.1210/endocr/bqae165. Endocrinology. 2025. PMID: 39715341 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources